These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25278477)

  • 1. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor-structure of the Italian version of the Scale Of Prodromal Symptoms (SOPS): a comparison with the English version.
    Comparelli A; Savoja V; Kotzalidis GD; Woods SW; Mosticoni S; Vassallo F; Soscia F; Piccione R; Palma G; Pucci D; Girardi P; Conti L; Tatarelli R
    Epidemiol Psychiatr Sci; 2011 Mar; 20(1):45-54. PubMed ID: 21657115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
    McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
    Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of active psychosis and first-episode psychosis negative symptoms.
    Lyne J; Joober R; Schmitz N; Lepage M; Malla A
    Early Interv Psychiatry; 2017 Feb; 11(1):63-71. PubMed ID: 25582878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients.
    Brucato G; First MB; Dishy GA; Samuel SS; Xu Q; Wall MM; Small SA; Masucci MD; Lieberman JA; Girgis RR
    Psychol Med; 2021 Jan; 51(1):112-120. PubMed ID: 31658912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting positive and negative symptom scores between PANSS and SAPS/SANS.
    van Erp TG; Preda A; Nguyen D; Faziola L; Turner J; Bustillo J; Belger A; Lim KO; McEwen S; Voyvodic J; Mathalon DH; Ford J; Potkin SG; Fbirn
    Schizophr Res; 2014 Jan; 152(1):289-94. PubMed ID: 24332632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program.
    Tso IF; Taylor SF; Grove TB; Niendam T; Adelsheim S; Auther A; Cornblatt B; Carter CS; Calkins R; Ragland JD; Sale T; McFarlane WR
    Early Interv Psychiatry; 2017 Feb; 11(1):14-22. PubMed ID: 25529847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research.
    Gaspar PA; Castillo RI; Maturana A; Villar MJ; Ulloa K; González G; Ibaceta O; Ortiz A; Corral S; Mayol R; De Angel V; Aburto MB; Martínez A; Corcoran CM; Silva H
    Early Interv Psychiatry; 2019 Apr; 13(2):328-334. PubMed ID: 30548415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
    Xu K; Krystal JH; Ning Y; Chen DC; He H; Wang D; Ke X; Zhang X; Ding Y; Liu Y; Gueorguieva R; Wang Z; Limoncelli D; Pietrzak RH; Petrakis IL; Zhang X; Fan N
    J Psychiatr Res; 2015 Feb; 61():64-72. PubMed ID: 25560772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factorial structure of the Scale of Prodromal Symptoms.
    Hawkins KA; McGlashan TH; Quinlan D; Miller TJ; Perkins DO; Zipursky RB; Addington J; Woods SW
    Schizophr Res; 2004 Jun; 68(2-3):339-47. PubMed ID: 15099615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
    Strauss GP; Pelletier-Baldelli A; Visser KF; Walker EF; Mittal VA
    Schizophr Res; 2020 Aug; 222():104-112. PubMed ID: 32522469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Strauss GP; Chapman HC
    Schizophr Res; 2018 Mar; 193():435-437. PubMed ID: 28779853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multidimensional measurement of the positive symptoms of psychosis.
    Steel C; Garety PA; Freeman D; Craig E; Kuipers E; Bebbington P; Fowler D; Dunn G
    Int J Methods Psychiatr Res; 2007; 16(2):88-96. PubMed ID: 17623388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.
    Fulford D; Niendam TA; Floyd EG; Carter CS; Mathalon DH; Vinogradov S; Stuart BK; Loewy RL
    Schizophr Res; 2013 Jun; 147(1):125-131. PubMed ID: 23587696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.